INTERNATIONAL PATENT: UNIVERSITY HEALTH NETWORK FILES APPLICATION FOR "PROTEASOME INHIBITION THERAPY FOR CDKL DEFICIENCY"

GENEVA, Dec. 7 -- UNIVERSITY HEALTH NETWORK (190 Elizabeth Street, R. Fraser Elliott Building - Room 1S-417Toronto, Ontario M5G 2C4) filed a patent application (PCT/CA2025/050724) for "PROTEASOME INHIBITION THERAPY FOR CDKL DEFICIENCY" on May 22, 2025. With publication no. WO/2025/245617, the details related to the patent application was published on Dec 04, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): EUBANKS, James (294 MacNab StreetDundas, Ontario L9H 2K7), FALLAH, Merrick (270 Rushton Road, Apt 803Toronto, Ontario M6G 0A5)

Abstract: There is described herein use of proteosome inhibit...